Washington: Cedars-Sinai researchers have found that a common vitamin may have the potential to fight certain “superbugs,” antibiotic-resistant staph infections that health experts see as a threat to public health.The research found that high doses of the nicotinamide form of vitamin B3 stimulated a specific gene (CEBPE), enhancing white blood cells’ ability to combat staph infections, including methicillin-resistant Staphylococcus aureus or MRSA.With research ongoing, including possible clinical trials in humans, the scientists caution consumers not to treat a suspected infection by taking vitamin B3. Instead, a physician should be consulted.“It’s critical that we find novel antimicrobial approaches to treat infection and not rely so heavily on antibiotics,” said George Liu, MD, PhD, a pediatric infectious disease physician at Cedars-Sinai’s Maxine Dunitz Children’s Health Centre and co-senior author of the study.“That’s why this discovery is so exciting. Our research indicates this common vitamin is potentially effective in fighting off and protecting against one of today’s most concerning public health threats,” he stated.
Finance Minister presents his maiden budget in Parliament
Budget 2014-15: IT exemption limit raised to Rs 2.5 lakh
Union Budget 2014: What`s cheaper, what`s dearer
We didn`t want to burden the common man: Arun Jaitley on budget